Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Abeona’s Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., ...
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who ...
A new generation of therapeutics looks beyond simply reengineering the gut microbiome to exploiting multiple pathways for ...
Fintel reports that on March 5, 2025, Oppenheimer initiated coverage of Abeona Therapeutics (NasdaqCM:ABEO) with a Outperform ...
Determinants of HIV cell tropism & chemokine receptor usage The V3 loop of HIV-1 gp120 is a primary determinant of cell tropism and chemokine receptor usage, whereas the V1/V2 region is involved ...
AI-assisted AAV capsid engineering has transformative potential in terms of accelerating and optimizing the development of gene therapies.
COLUMN. The fracture the US president is causing between the US and Europe is giving away points to Russia and China, writes ...
The authors are grateful to the Council of Scientific and Industrial Research (CSIR-CCMB), India, for encouragement and support for this work. NIH Awards (R37DA025576; R01MH085259) also support SK ...